IL6 and COVID-19: According to a study by Huang et al. [106], chemokine and cytokine analyses from COVID-19 patients revealed increased amounts of proinflammatory cytokines, such as IL-6, IL1β, IFNγ, IP10, and MCP1, in the serum.